A reliable and commercially scalable supply of the therapeutic radioisotope, Cu-67, is a critical component of Clarity’s success in developing life changing treatments for children and adults living with cancer. This is why we have partnered with NorthStar Medical Isotopes, a leader in the manufacturing of therapeutic radioisotopes, such as Cu-67, who are routinely producing high activity, high specific activity and high purity Cu-67 for use in Clarity’s ongoing clinical programs.
Watch this video for an exciting ‘behind the scenes’ look into the process and team that produce Cu-67 for use with Clarity’s Targeted Copper Theranostics.
